
Advancing Monoclonal Antibody Manufacturing: Process Optimization, Cost Reduction Strategies, and Emerging Technologies
Introduction Monoclonal antibodies (mAbs) have emerged as a cornerstone of modern therapeutic interventions, revolutionizing the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory conditions.1–3 Despite their clinical …